Real-life observational cohort verifies high efficacy of dupilumab for chronic rhinosinusitis with nasal polyps

Allergy. 2022 Feb;77(2):670-674. doi: 10.1111/all.15134. Epub 2021 Oct 18.
No abstract available

Keywords: biological therapy; dupilumab; observational study; sinusitis; treatment outcome.

Publication types

  • Letter
  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Chronic Disease
  • Humans
  • Nasal Polyps* / complications
  • Nasal Polyps* / drug therapy
  • Rhinitis* / complications
  • Rhinitis* / drug therapy
  • Sinusitis* / drug therapy

Substances

  • Antibodies, Monoclonal, Humanized
  • dupilumab